These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 21181549)

  • 1. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
    Wijagkanalan W; Kawakami S; Hashida M
    Pharm Res; 2011 Jul; 28(7):1500-19. PubMed ID: 21181549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers.
    Yellepeddi VK; Ghandehari H
    Expert Opin Drug Deliv; 2019 Oct; 16(10):1051-1061. PubMed ID: 31414922
    [No Abstract]   [Full Text] [Related]  

  • 3. Dendrimers for pharmaceutical and biomedical applications.
    Yang H; Kao WJ
    J Biomater Sci Polym Ed; 2006; 17(1-2):3-19. PubMed ID: 16411595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical and biomedical potential of surface engineered dendrimers.
    Satija J; Gupta U; Jain NK
    Crit Rev Ther Drug Carrier Syst; 2007; 24(3):257-306. PubMed ID: 17956215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.
    Menjoge AR; Kannan RM; Tomalia DA
    Drug Discov Today; 2010 Mar; 15(5-6):171-85. PubMed ID: 20116448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
    Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
    Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals.
    Samad A; Alam MI; Saxena K
    Curr Pharm Des; 2009; 15(25):2958-69. PubMed ID: 19754372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges.
    Wu LP; Ficker M; Christensen JB; Trohopoulos PN; Moghimi SM
    Bioconjug Chem; 2015 Jul; 26(7):1198-211. PubMed ID: 25654320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in dendrimer-based nanomedicine development.
    Kim Y; Park EJ; Na DH
    Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-skin permeability relationship of dendrimers.
    Venuganti VV; Sahdev P; Hildreth M; Guan X; Perumal O
    Pharm Res; 2011 Sep; 28(9):2246-60. PubMed ID: 21633876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimers as versatile platform in drug delivery applications.
    Svenson S
    Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic systems in drug delivery applications.
    Jain NK; Asthana A
    Expert Opin Drug Deliv; 2007 Sep; 4(5):495-512. PubMed ID: 17880273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimer toxicity: Let's meet the challenge.
    Jain K; Kesharwani P; Gupta U; Jain NK
    Int J Pharm; 2010 Jul; 394(1-2):122-42. PubMed ID: 20433913
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wei X; Liu Z; Zhao Z
    Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances of dendrimers in delivery of genes and drugs.
    Gao Y; Gao G; He Y; Liu T; Qi R
    Mini Rev Med Chem; 2008 Aug; 8(9):889-900. PubMed ID: 18691146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.
    Nance E; Zhang F; Mishra MK; Zhang Z; Kambhampati SP; Kannan RM; Kannan S
    Biomaterials; 2016 Sep; 101():96-107. PubMed ID: 27267631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine.
    Mariyam M; Ghosal K; Thomas S; Kalarikkal N; Latha MS
    Mini Rev Med Chem; 2018 Feb; 18(5):439-457. PubMed ID: 28618985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V; Jain NK
    Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.